REGULATED PRESS RELEASE published on 06/30/2025 at 22:30, 5 months 4 days ago Information on the Annual Financial Statements Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE published on 06/30/2025 at 22:29, 5 months 4 days ago Information on the Annual Financial Statements Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF published on 06/19/2025 at 23:05, 5 months 15 days ago Biophytis Temporarily Suspends Share Trading Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension
REGULATED PRESS RELEASE published on 06/19/2025 at 23:00, 5 months 15 days ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading shares on Euronext due to delayed financial report. Expected to resume after report publication. Company info included Biophytis Euronext Trading Financial Report Suspension
PRESS RELEASE published on 06/19/2025 at 22:59, 5 months 15 days ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading of its shares by Euronext due to non-publication of annual financial report for 2024, expected to resume after report publication Biophytis Shares Euronext Trading Suspension
BRIEF published on 06/04/2025 at 07:05, 6 months 1 day ago Biophytis to Attend BIO International Convention in Boston Biophytis Biotechnology Partnerships BIO101 Convention
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 6 months 1 day ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
BRIEF published on 05/30/2025 at 22:05, 6 months 5 days ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 6 months 5 days ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
PRESS RELEASE published on 05/30/2025 at 21:59, 6 months 5 days ago Information on the Annual Financial Statements Biophytis postpones 2024 annual financial statements publication due to technical audit issues, reschedules General Meeting of shareholders following legal procedures Shareholders Financial Statements Biophytis Meeting Audit
Published on 12/05/2025 at 02:35, 10 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 15 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 15 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 10 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 15 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 16 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 31 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 31 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 31 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
